Compound Info | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
NAs | Base Info | ||||||||||
ID | Cluster | Name | Target | MolWt | |||||||
![]() |
NAs.000655 | 4 |
|
745.425 |
Chemical Representations | |
---|---|
InChI | InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 |
InChI Key | ACFIXJIJDZMPPO-NNYOXOHSSA-N |
SMILES | NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1 |
Molecular Formula | C21H30N7O17P3 |
Functional Fragments | ||
---|---|---|
Base | Ribose | Phosphate |
![]() Match
|
![]() Match
|
![]() |
Calculated Properties | ||
---|---|---|
logP | -2.569 | Computed by RDKit |
Heavy Atom Count | 48 | Computed by RDKit |
Ring Count | 5 | Computed by RDKit |
Hydrogen Bond Acceptor Count | 19 | Computed by RDKit |
Hydrogen Bond Donor Count | 9 | Computed by RDKit |
Rotatable Bond Count | 13 | Computed by RDKit |
Topological Polar Surface Area | 364.150 | Computed by RDKit |
Activity Data | ||||||
---|---|---|---|---|---|---|
Target | Activity type | Relation | Value | Unit | Assay | Source |
SARS-CoV-2 | Inhibition | = | -9.07 | % | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging | CHEMBL4303101 |
NAD(+) hydrolase SARM1 | Activity | Substrate activity at StrepTag-tagged human SARM1 TIR (561 to 724 residues) expressed in HEK293T cells assessed as increase in in NADase activity in presence of NAD+ incubated for 60 mins by HPLC analysis | CHEMBL4421736 | |||
NAD(+) hydrolase SARM1 | Activity | Substrate activity at StrepTag-tagged human SARM1 TIR (561 to 724 residues) expressed in HEK293T cells assessed as increase in in NADase activity at 100 uM in presence of NAD+ incubated for 60 mins by HPLC analysis | CHEMBL4421736 | |||
Replicase polyprotein 1ab | Inhibition | = | 6.9929999999999986 | % | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | CHEMBL4495564 |
SARS-CoV-2 | Inhibition | = | -0.05 | % | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | CHEMBL4495565 |
SARS-CoV-2 | Inhibition | = | -0.05 | % | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | CHEMBL4495565 |
Unchecked | Delta Tm | = | 3.0 | degrees C | Binding affinity to Pseudomonas aeruginosa MurB assessed as change in melting temperature at 1 mM by differential scanning fluorimetry | CHEMBL5038657 |